P Nafteux
Overview
Explore the profile of P Nafteux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mortensen H, Populaire P, Hoffmann L, Moeller D, Appelt A, Nafteux P, et al.
Radiother Oncol
. 2023 Nov;
190:109980.
PMID: 37935284
No abstract available.
2.
Soderstrom H, Moons J, Nafteux P, Uzun E, Grimminger P, Luyer M, et al.
Ann Surg Oncol
. 2023 Oct;
30(13):8244-8250.
PMID: 37782412
Background: Studies have shown minimally invasive esophagectomy (MIE) to be a feasible surgical technique in treating esophageal carcinoma. Postoperative complications have been extensively reviewed, but literature focusing on intraoperative complications...
3.
Depypere L, Van Veer H, Nafteux P, Coosemans W
Acta Chir Belg
. 2022 Oct;
123(6):647-653.
PMID: 36227741
Background: In Belgium, no publicly available information exists on the spread, quality, results nor follow-up of antireflux and hiatal hernia surgery, in contrast to the recently centralized esophageal cancer surgery....
4.
De Meulder S, Sagaert X, Brems H, Brekelmans C, Nafteux P, Topal B, et al.
Acta Gastroenterol Belg
. 2022 Mar;
85(1):1-5.
PMID: 35304987
Introduction: Patients with gastroesophageal adenocarcinoma (GEC) with microsatellite instability-high (MSI-H) or Epstein Barr Virus positivity (EBV+) might be good candidates for immunotherapy. Incidences of about 10% have been reported for...
5.
Schoffski P, Timmermans I, Hompes D, Stas M, Boecxstaens V, Sinnaeve F, et al.
Sarcoma
. 2021 Feb;
2021:4653987.
PMID: 33628084
[This corrects the article DOI: 10.1155/2020/1385978.].
6.
Moons J, Depypere L, Lerut T, van Achterberg T, Coosemans W, Van Veer H, et al.
Dis Esophagus
. 2021 Feb;
34(10).
PMID: 33598683
Enhanced recovery pathways (ERP) have the potential to improve clinical outcomes. Aim of this study was to determine the impact of ERP on perioperative results as compared with traditional care...
7.
Muller P, Kapp J, Vetter D, Bonavina L, Brown W, Castro S, et al.
Dis Esophagus
. 2020 Sep;
34(6).
PMID: 32960264
There are no internationally recognized criteria available to determine preparedness for hospital discharge after esophagectomy. This study aims to achieve international consensus using Delphi methodology. The expert panel consisted of...
8.
Schoffski P, Timmermans I, Hompes D, Stas M, Sinnaeve F, De Leyn P, et al.
Sarcoma
. 2020 Apr;
2020:1385978.
PMID: 32300277
Background: Solitary fibrous tumor (SFT) is a rare variant of soft tissue sarcoma (STS). . We reviewed SFT patients (pts) treated at our institution between 12/1990 and 09/2017. Results: We...
9.
Struyve M, De Vloo C, Van Veer H, Depypere L, Nafteux P, Roelandt P
Acta Gastroenterol Belg
. 2020 Jan;
82(4):529-531.
PMID: 31950809
Persisting suture dehiscence with oesophageal anastomotic leaks after thoracic surgery is a difficult complication, especially when a surgical repair fails. We report here endoscopic vacuum-assisted closure therapy as a novel...
10.
Konradsson M, van Berge Henegouwen M, Bruns C, Chaudry M, Cheong E, Cuesta M, et al.
Dis Esophagus
. 2019 Oct;
33(4).
PMID: 31608938
Delayed gastric conduit emptying (DGCE) after esophagectomy for cancer is associated with adverse outcomes and troubling symptoms. Widely accepted diagnostic criteria and a symptom grading tool for DGCE are missing....